BioNanomatrix Opens San Diego Office; Moves into Product Development

"Now that we have built a prototype field-testable system, we need to begin to commercialize applications on the platform," said BioNanomatrix CEO Erik Holmlin.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories